{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:21:19Z","timestamp":1759936879797},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1990,7,1]],"date-time":"1990-07-01T00:00:00Z","timestamp":646790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Japanese Journal of Surgery"],"published-print":{"date-parts":[[1990,7]]},"DOI":"10.1007\/bf02470819","type":"journal-article","created":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T13:34:59Z","timestamp":1153316099000},"page":"369-375","source":"Crossref","is-referenced-by-count":7,"title":["The effect of adjuvant therapy with or without tamoxifen on the endocrine function of patients with breast cancer"],"prefix":"10.1007","volume":"20","author":[{"given":"Tadaki","family":"Yasumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Akami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Mitsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Naitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takara","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Honjyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02470819_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198107023050101","volume":"305","author":"B Fisher","year":"1981","unstructured":"Fisher B, Redmond C, Brown A, Wolmark N, Wittleff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R, LiCalzi N, Geggie P, Cambell T, Elias EG, Prager D, Kootz P, Volk H, Dimitrov N, Gradner B, Lerner H, Shibata H, and other NSABP investigators. Treatment of primary breast cancer with chemotherapy and tamoxifen. New Engl J Med 1981; 305: 1\u20136.","journal-title":"New Engl J Med"},{"key":"BF02470819_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-642-71506-8_4","volume-title":"Endocrine therapy of breast cancer, Concept and Strategie","author":"VC Jordan","year":"1986","unstructured":"Jordan VC. Oestrogen and anti-oestrogen action: A hypothesis for the regulation of breast cancer cell replication. In Cavalli F ed. Endocrine therapy of breast cancer, Concept and Strategie. Berlin: Springer-Verlag. 1986; 41\u201349."},{"key":"BF02470819_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","volume":"25","author":"BJA Furr","year":"1984","unstructured":"Furr BJA, Jordan VC. The pharmacology and clinical uses of tamoxifen. Pharmac Ther 1984; 25: 127\u2013250.","journal-title":"Pharmac Ther"},{"key":"BF02470819_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000180788","volume":"27","author":"H Honjyo","year":"1987","unstructured":"Honjyo H, Kitawaki J, Itoh M, Yasuda J, Urabe M, Naitoh K, Yamamoto T, Okada H. Serum and urine estrone sulfate during the menstrual cycle, measured by a direct radioimmunoassay, and fate of exogeneous injected estrone sulfate. Hormone Res 1987; 27: 61\u201368.","journal-title":"Hormone Res"},{"key":"BF02470819_CR5","first-page":"483","volume":"4","author":"H Honjyo","year":"1987","unstructured":"Honjyo H. Aging of ovary and estrone sulfate. Adv Obstet Gynecol 1987; 4: 483\u2013487.","journal-title":"Adv Obstet Gynecol"},{"key":"BF02470819_CR6","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(77)92716-7","volume":"1","author":"DP Rose","year":"1977","unstructured":"Rose DP, Davis TE. Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet 1977; 1: 1174\u20131176.","journal-title":"Lancet"},{"key":"BF02470819_CR7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/1097-0142(19830301)51:5<803::AID-CNCR2820510509>3.0.CO;2-V","volume":"51","author":"AM Dnistrian","year":"1983","unstructured":"Dnistrian AM, Schwartz MK, Fracchia AA, Kaufman RJ, Hakes TB, Carrie VE. Endocrine consequence of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients. Cancer 1983; 51: 803\u2013807.","journal-title":"Cancer"},{"key":"BF02470819_CR8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1210\/jcem-54-2-404","volume":"54","author":"S Helgason","year":"1982","unstructured":"Helgason S, Wilkins N, Carlstrom K, Damber MG. A comparative study of the estrogen effects of tamoxifen and 17\u03b2 estradiol in postmenopausal women. J Clin Endocrinol Metabol 1982; 54: 404\u2013407.","journal-title":"J Clin Endocrinol Metabol"},{"key":"BF02470819_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/030089168607200108","volume":"72","author":"G Delrio","year":"1986","unstructured":"Delrio G, DePlacido S, Pegliarulo C, d'Istria M, Fasano S, Marinelli A, Citarella F, DeSio L, Contegiacomo A, Iaffaioli RV, Petrilla G, Ricciardi I, Bianco AR. Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen. Tumori 1986; 72: 53\u201361.","journal-title":"Tumori"},{"key":"BF02470819_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/1097-0142(19850701)56:1<63::AID-CNCR2820560111>3.0.CO;2-7","volume":"56","author":"AM Dnistrian","year":"1985","unstructured":"Dnistrian AM, Greenberg EJ, Dillon HJ, Hakes TB, Fracchia AA, Schwartz MK. Chemohormonal therapy and endocrine function in breast cancer patients. Cancer 1985; 56: 63\u201370.","journal-title":"Cancer"},{"key":"BF02470819_CR11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8","volume":"39","author":"N Koyama","year":"1977","unstructured":"Koyama N, Wada T, Nishizawa Y, Iwanaga T, Aoki Y, Terazawa T, Kosaki G, Yamamoto T, Wada A. Cyclophosphamide-induced ovarian failure and its-therapeutic significance in patients with breast cancer. Cancer 1977; 39: 1403\u20131409.","journal-title":"Cancer"},{"key":"BF02470819_CR12","first-page":"4043","volume":"40","author":"DP Rose","year":"1980","unstructured":"Rose DP, Davis TE. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer Res 1980; 40: 4043\u20134047.","journal-title":"Cancer Res"},{"key":"BF02470819_CR13","first-page":"252","volume":"4","author":"AF Bianco","year":"1985","unstructured":"Bianco AF, DeParcido S, Pagliarulo C, D'Istria M, DeSio L, Ricciarde I, Delrio G. Effect of adjuvant tamoxifen and CMF on endocrine function of patients with operable breast cancer. Chemotherapia 1985; 4: 252\u2013255.","journal-title":"Chemotherapia"},{"key":"BF02470819_CR14","first-page":"624","volume":"47","author":"VC Jordan","year":"1987","unstructured":"Jordan VC, Fritz NF, Tormey DC. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Cancer Res 1987; 47: 624\u2013630.","journal-title":"Cancer Res"},{"key":"BF02470819_CR15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI109475","volume":"64","author":"BM Sherman","year":"1979","unstructured":"Sherman BM, Chapler FK, Crickard K, Wycoff D. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest 1979; 64: 398\u2013404.","journal-title":"J Clin Invest"},{"key":"BF02470819_CR16","first-page":"265","volume-title":"Estrogen\/antiestrogen action and breast cancer therapy","author":"RL Sutherland","year":"1986","unstructured":"Sutherland RL, Reddel RR, Murphy LC, Taylor IW. Effects of antiestrogens on cell cycle progression. In: Jordan VC. Estrogen\/antiestrogen action and breast cancer therapy. London: The University of Winsconsin Press. 1986; 265\u2013281."},{"key":"BF02470819_CR17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/256592a0","volume":"256","author":"ME Lippman","year":"1975","unstructured":"Lippman ME, Bolan G. Oestrogen-responsive human breast cancer in long term tissue culture. Nature 1975; 256: 592\u2013593.","journal-title":"Nature"},{"key":"BF02470819_CR18","first-page":"317","volume":"42","author":"E Coezy","year":"1982","unstructured":"Coezy E, Borgna JL, Rochefort H. Tamoxifen and metabolite in MCH-7 cells correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982; 42: 317\u2013323.","journal-title":"Cancer Res"},{"key":"BF02470819_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1677\/joe.0.0830401","volume":"83","author":"CP Daniel","year":"1979","unstructured":"Daniel CP, Gaskell SJ, Bishop H, Nicholson RI. Determination of tamoxifen and an hydroxylated metabolite in plasma from patients with advanced breast cancer using gas chromatography-mass spectrometry. J Endocr 1979; 83: 401\u2013408.","journal-title":"J Endocr"},{"key":"BF02470819_CR20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2964(81)90220-6","volume":"17","author":"M Edery","year":"1981","unstructured":"Edery M, Goussard J, Dehennin L, Scholler R, Reiffstec J, Drosdowsky MA. Endogeneous oestradiol-17 concentration in breast tumors determined by mass fragmentography and by radioimmunoassay; Relationship to receptor content. Euro J Cancer 1981; 17: 115\u2013120.","journal-title":"Euro J Cancer"},{"key":"BF02470819_CR21","doi-asserted-by":"crossref","unstructured":"Naitoh K, Honjyo H, Yamamoto T, Urabe M, Ogino Y, Yasumura T, Nambara T. Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer. J. Steroi Biochem 1989: (in press).","DOI":"10.1016\/0022-4731(89)90408-1"},{"key":"BF02470819_CR22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.1985.3.2.144","volume":"3","author":"SG Taylor","year":"1985","unstructured":"Taylor SG, Kalish IV, Olson JE, Cummings F, Bennett JM, Falkson G, Tormey DC, Carbone PP. Adjuvant CMFPversus CMFP plus tamoxifenversus observation alone in postoperative node positive breast cancer patients: Three year results of an estrogen cooperative oncology group study. J Clin Oncol 1985; 3: 144\u2013154.","journal-title":"J Clin Oncol"}],"container-title":["The Japanese Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02470819.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02470819\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02470819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T15:10:47Z","timestamp":1558278647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02470819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,7]]}},"alternative-id":["BF02470819"],"URL":"https:\/\/doi.org\/10.1007\/bf02470819","relation":{},"ISSN":["0047-1909","1436-2813"],"issn-type":[{"value":"0047-1909","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,7]]}}}